← Back to Search

Soy protein isolate for Kidney Failure

N/A

Waitlist Available

Research Sponsored by University of Florida

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 12 weeks of the study

Awards & highlights

Study Summary

This trial will study the effects of two different types of high-protein beverages on people with CKD undergoing hemodialysis.

Eligible Conditions

Kidney Failure
Chronic Kidney Disease

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 12 weeks of the study

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 12 weeks of the study

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 12 weeks of the study for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

C-reactive protein

IL-6

Normalized protein catabolic rate

Secondary outcome measures

Isoflavones - Serum values of Genistin and Daidzin

Malnutrition Inflammation Score

Serum Amino acid profiles of essential and non-essential amino acids

+1 more

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: Soy protein isolateExperimental Treatment1 Intervention

Participants will receive 120 mls of soy protein isolate (total of 20 g protein) to consume 3x/week after dialysis treatment for 4 weeks.

Group II: Whey protein isolateActive Control1 Intervention

Participants will receive 120 mls of whey protein isolate (total of 20 g protein) to consume 3x/week after dialysis treatment for 4 weeks.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Soy protein isolate

2022

N/A

~30

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

University of FloridaLead Sponsor

1,340 Previous Clinical Trials

715,690 Total Patients Enrolled

3 Trials studying Kidney Failure

119 Patients Enrolled for Kidney Failure

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

How many participants have agreed to take part in this experiment thus far?

"Indeed, clinicaltrials.gov verifies that this research endeavour is presently enrolling participants. This investigation was originally made public on August 5th 2022 and has since been revised as of August 7th 2022. With 1 site available, recruitment for the trial will be capped at 22 members."

Answered by AI

What is the primary purpose of this research endeavor?

"The main endpoint of this 12-week study is to analyse C-reactive protein levels. Secondary objectives include a serum analysis on essential and nonessential amino acids, observing malnutrition via the Malnutrition Inflammation Score (with questions ranging from 0 [normal] to 30 [severe]) as well as uremic toxins such as p-cresol sulfate and indoxyl sulfate which will be assessed through LC/MS technology."

Answered by AI

Are there any current opportunities to join this investigation?

"Affirmative. According to clinicaltrials.gov, this examination is presently searching for participants and was initially posted on August 5th 2022 before being updated on the 7th of that same month. Twenty-two patients are required across one medical centre."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

High-protein Oral Supplement Improves Normalized Protein Catabolic Rate and Inflammation Markers

Jeanette Andrade 2022. "High-protein Oral Supplement Improves Normalized Protein Catabolic Rate and Inflammation Markers". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05227755.